Improving the activity of BH3 mimetic venetoclax: a case study
Andrew Wei, MBBS, PhD, FRACP, FRCPA, from Monash University, Melbourne, Australia, discusses clinical trials investigating the effect of BH3 mimetic drugs, such as venetoclax, on acute myeloid leukemi...
Author: VJHemOnc
Added: 06/11/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts